Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence
- PMID: 2553162
Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence
Abstract
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) enhanced superoxide release and membrane depolarization in parallel in human granulocytes stimulated by the receptor-mediated agonists, N-formyl-methionyl-leucyl-phenylalanine and wheat germ agglutinin, but not by the Ca2+ ionophore ionomycin and phorbol myristate acetate, which bypass the receptors to stimulate the cells. The optimal effect was obtained by pretreatment of cells with 25 to 50 ng/mL (1.3 to 2.6 nmol/L) rhG-CSF for 10 minutes at 37 degrees C. rhG-CSF produced by bacteria and mammalian cells had identical biological effects on a molar basis. rhG-CSF neither affected stimulus-induced increase in cytoplasmic free Ca2+ nor changed the number and affinity of N-formyl-methionyl-leucyl-phenylalanine receptors. The priming effect of rhG-CSF was temperature dependent and did not require new protein synthesis. rhG-CSF increased the expression of C3bi receptors on human granulocytes and enhanced granulocyte adherence to nylon fiber. The optimal effect was obtained by pretreatment of cells with 25 to 50 ng/mL rhG-CSF for 30 minutes at 37 degrees C. rhG-CSF had no effect on human monocytes. These findings demonstrate that rhG-CSF can selectively stimulate mature granulocyte functions.
Similar articles
-
In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.Blood. 1989 Dec;74(8):2743-8. Blood. 1989. PMID: 2479431
-
Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: qualitative and quantitative differences.Biochem Biophys Res Commun. 1990 Aug 31;171(1):491-7. doi: 10.1016/0006-291x(90)91420-w. Biochem Biophys Res Commun. 1990. PMID: 1697466
-
Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release.Exp Hematol. 1996 Mar;24(4):559-67. Exp Hematol. 1996. PMID: 8608807
-
Rapid priming of human monocytes by human hematopoietic growth factors: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists.Blood. 1992 Mar 15;79(6):1553-7. Blood. 1992. PMID: 1312371
-
Effects and safety of granulocyte colony-stimulating factor in healthy volunteers.Curr Opin Hematol. 2009 Jan;16(1):35-40. doi: 10.1097/MOH.0b013e328319913c. Curr Opin Hematol. 2009. PMID: 19057203 Free PMC article. Review.
Cited by
-
Kinetics of neutrophils in mice exposed to radiation and/or granulocyte colony-stimulating factor treatment.Radiat Res. 2013 Aug;180(2):177-88. doi: 10.1667/RR3055.1. Epub 2013 Jul 5. Radiat Res. 2013. PMID: 23829559 Free PMC article.
-
Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor.Ann Hematol. 1993 Oct;67(4):201-2. doi: 10.1007/BF01695869. Ann Hematol. 1993. PMID: 7692983 No abstract available.
-
Hematopoietic growth factors in cancer patients with invasive fungal infections.Eur J Clin Microbiol Infect Dis. 1997 Jan;16(1):56-63. doi: 10.1007/BF01575122. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9063675 Review.
-
Monitoring of immunotherapy with cytokines or monoclonal antibodies.Cytotechnology. 1995 Jan;18(1-2):93-106. doi: 10.1007/BF00744324. Cytotechnology. 1995. PMID: 22358641
-
Guidelines for safety management of granulocyte transfusion in Japan.Int J Hematol. 2010 Mar;91(2):201-8. doi: 10.1007/s12185-010-0506-z. Epub 2010 Feb 11. Int J Hematol. 2010. PMID: 20146029
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous